1 The substrate of nitric oxide synthase (NOS), L-arginine (L-Arg, 0.01 mM71 mM), induced endothelium-independent relaxations in segments of middle cerebral arteries (MCAs) from normotensive Wistar-Kyoto (WKY) and hypertensive rats (SHR) precontracted with prostaglandin F 2a (PGF 2a ). These relaxations were higher in SHR than WKY arteries. 2 L-N G -nitroarginine methyl ester (L-NAME) and 2-amine-5,6-dihydro-6-methyl-4H-1,3-tiazine (AMT), unspeci®c and inducible NOS (iNOS) inhibitors, respectively, reduced those relaxations, specially in SHR.3 Four-and seven-hours incubation with dexamethasone reduced the relaxations in MCAs from WKY and SHR, respectively. 4 Polymyxin B and calphostin C, protein kinase C (PKC) inhibitors, reduced the L-Arg-induced relaxation. 5 Lipopolysaccharide (LPS, 7 h incubation) unaltered and inhibited these relaxations in WKY and SHR segments, respectively. LPS antagonized the e ect polymyxin B in WKY and potentiated LArg-induced relaxations in SHR in the presence of polymyxin B. 6 The contraction induced by PGF 2a was greater in SHR than WKY arteries. This contraction was potentiated by dexamethasone and polymyxin B although the e ect of polymyxin B was higher in SHR segments. LPS reduced that contraction and antagonized dexamethasone-and polymyxin Binduced potentiation, these e ects being greater in arteries from SHR. 7 These results suggest that in MCAs: (1) the induction of iNOS participates in the L-Arg relaxation and modulates the contraction to PGF 2a ; (2) that induction is partially mediated by a PKC-dependent mechanism; and (3) the involvement of iNOS in such responses is greater in the hypertensive strain.